COVID-19 Impact on Rheumatoid Arthritis (RA) Drugs Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Rheumatoid Arthritis (RA) Drugs, including the following market information:
Major competitors identified in this market include AbbVie, Roche, Johnson & Johnson, Amgen, Inc., Pfizer, Merck, Bristol-Myers Squibb, UCB, GlaxoSmithKline, Sanofi, Abbott Laboratories, Teva Pharmaceutical, etc.
Based on the Region:
- Global Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Rheumatoid Arthritis (RA) Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Rheumatoid Arthritis (RA) Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include AbbVie, Roche, Johnson & Johnson, Amgen, Inc., Pfizer, Merck, Bristol-Myers Squibb, UCB, GlaxoSmithKline, Sanofi, Abbott Laboratories, Teva Pharmaceutical, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Oral
- Injection
- External
- Medical Care
- Personal Care
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Rheumatoid Arthritis (RA) Drugs Industry
1.7 COVID-19 Impact: Rheumatoid Arthritis (RA) Drugs Market Trends
2 GLOBAL RHEUMATOID ARTHRITIS (RA) DRUGS QUARTERLY MARKET SIZE ANALYSIS
2.1 Rheumatoid Arthritis (RA) Drugs Business Impact Assessment - COVID-19
2.1.1 Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Rheumatoid Arthritis (RA) Drugs Headquarters and Area Served
3.3 Date of Key Players Enter into Rheumatoid Arthritis (RA) Drugs Market
3.4 Key Players Rheumatoid Arthritis (RA) Drugs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RHEUMATOID ARTHRITIS (RA) DRUGS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Injection
1.4.3 External
4.2 By Type, Global Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RHEUMATOID ARTHRITIS (RA) DRUGS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Medical Care
5.5.2 Personal Care
5.2 By Application, Global Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021
5.2.1 By Application, Global Rheumatoid Arthritis (RA) Drugs Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.2.3 Roche Rheumatoid Arthritis (RA) Drugs Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Business Overview
7.3.2 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.3.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Introduction
7.3.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.4 Amgen, Inc.
7.4.1 Amgen, Inc. Business Overview
7.4.2 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.4.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Introduction
7.4.4 Amgen, Inc. Response to COVID-19 and Related Developments
7.5 Pfizer
7.5.1 Pfizer Business Overview
7.5.2 Pfizer Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.5.3 Pfizer Rheumatoid Arthritis (RA) Drugs Product Introduction
7.5.4 Pfizer Response to COVID-19 and Related Developments
7.6 Merck
7.6.1 Merck Business Overview
7.6.2 Merck Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.6.3 Merck Rheumatoid Arthritis (RA) Drugs Product Introduction
7.6.4 Merck Response to COVID-19 and Related Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Business Overview
7.7.2 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.7.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Introduction
7.7.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.8 UCB
7.8.1 UCB Business Overview
7.8.2 UCB Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.8.3 UCB Rheumatoid Arthritis (RA) Drugs Product Introduction
7.8.4 UCB Response to COVID-19 and Related Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Business Overview
7.9.2 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.9.3 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Product Introduction
7.9.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.10 Sanofi
7.10.1 Sanofi Business Overview
7.10.2 Sanofi Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.10.3 Sanofi Rheumatoid Arthritis (RA) Drugs Product Introduction
7.10.4 Sanofi Response to COVID-19 and Related Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Business Overview
7.11.2 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.11.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Introduction
7.11.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.12 Teva Pharmaceutical
7.12.1 Teva Pharmaceutical Business Overview
7.12.2 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.12.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Introduction
7.12.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Rheumatoid Arthritis (RA) Drugs Industry
1.7 COVID-19 Impact: Rheumatoid Arthritis (RA) Drugs Market Trends
2 GLOBAL RHEUMATOID ARTHRITIS (RA) DRUGS QUARTERLY MARKET SIZE ANALYSIS
2.1 Rheumatoid Arthritis (RA) Drugs Business Impact Assessment - COVID-19
2.1.1 Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Rheumatoid Arthritis (RA) Drugs Headquarters and Area Served
3.3 Date of Key Players Enter into Rheumatoid Arthritis (RA) Drugs Market
3.4 Key Players Rheumatoid Arthritis (RA) Drugs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RHEUMATOID ARTHRITIS (RA) DRUGS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Oral
1.4.2 Injection
1.4.3 External
4.2 By Type, Global Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RHEUMATOID ARTHRITIS (RA) DRUGS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Medical Care
5.5.2 Personal Care
5.2 By Application, Global Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021
5.2.1 By Application, Global Rheumatoid Arthritis (RA) Drugs Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.2.3 Roche Rheumatoid Arthritis (RA) Drugs Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Business Overview
7.3.2 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.3.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Introduction
7.3.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.4 Amgen, Inc.
7.4.1 Amgen, Inc. Business Overview
7.4.2 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.4.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Introduction
7.4.4 Amgen, Inc. Response to COVID-19 and Related Developments
7.5 Pfizer
7.5.1 Pfizer Business Overview
7.5.2 Pfizer Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.5.3 Pfizer Rheumatoid Arthritis (RA) Drugs Product Introduction
7.5.4 Pfizer Response to COVID-19 and Related Developments
7.6 Merck
7.6.1 Merck Business Overview
7.6.2 Merck Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.6.3 Merck Rheumatoid Arthritis (RA) Drugs Product Introduction
7.6.4 Merck Response to COVID-19 and Related Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Business Overview
7.7.2 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.7.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Introduction
7.7.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.8 UCB
7.8.1 UCB Business Overview
7.8.2 UCB Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.8.3 UCB Rheumatoid Arthritis (RA) Drugs Product Introduction
7.8.4 UCB Response to COVID-19 and Related Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Business Overview
7.9.2 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.9.3 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Product Introduction
7.9.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.10 Sanofi
7.10.1 Sanofi Business Overview
7.10.2 Sanofi Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.10.3 Sanofi Rheumatoid Arthritis (RA) Drugs Product Introduction
7.10.4 Sanofi Response to COVID-19 and Related Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Business Overview
7.11.2 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.11.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Introduction
7.11.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.12 Teva Pharmaceutical
7.12.1 Teva Pharmaceutical Business Overview
7.12.2 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2020
7.12.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Introduction
7.12.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Rheumatoid Arthritis (RA) Drugs Assessment
Table 9. COVID-19 Impact: Rheumatoid Arthritis (RA) Drugs Market Trends
Table 10. COVID-19 Impact Global Rheumatoid Arthritis (RA) Drugs Market Size
Table 11. Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Rheumatoid Arthritis (RA) Drugs Market Growth Drivers
Table 14. Global Rheumatoid Arthritis (RA) Drugs Market Restraints
Table 15. Global Rheumatoid Arthritis (RA) Drugs Market Opportunities
Table 16. Global Rheumatoid Arthritis (RA) Drugs Market Challenges
Table 17. By Players, Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Rheumatoid Arthritis (RA) Drugs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Rheumatoid Arthritis (RA) Drugs Market
Table 21. Key Players Rheumatoid Arthritis (RA) Drugs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Rheumatoid Arthritis (RA) Drugs Market Size 2019-2021, (US$ Million)
Table 24. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Rheumatoid Arthritis (RA) Drugs Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Rheumatoid Arthritis (RA) Drugs Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product
Table 68. Johnson & Johnson Response to COVID-19 and Related Developments
Table 69. Amgen, Inc. Business Overview
Table 70. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product
Table 72. Amgen, Inc. Response to COVID-19 and Related Developments
Table 73. Pfizer Business Overview
Table 74. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Pfizer Rheumatoid Arthritis (RA) Drugs Product
Table 76. Pfizer Response to COVID-19 and Related Developments
Table 77. Merck Business Overview
Table 78. Merck Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Merck Rheumatoid Arthritis (RA) Drugs Product
Table 80. Merck Response to COVID-19 and Related Developments
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product
Table 84. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 85. UCB Business Overview
Table 86. UCB Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. UCB Rheumatoid Arthritis (RA) Drugs Product
Table 88. UCB Response to COVID-19 and Related Developments
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Product
Table 92. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 93. Sanofi Business Overview
Table 94. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sanofi Rheumatoid Arthritis (RA) Drugs Product
Table 96. Sanofi Response to COVID-19 and Related Developments
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product
Table 100. Abbott Laboratories Response to COVID-19 and Related Developments
Table 101. Teva Pharmaceutical Business Overview
Table 102. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product
Table 104. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Rheumatoid Arthritis (RA) Drugs Assessment
Table 9. COVID-19 Impact: Rheumatoid Arthritis (RA) Drugs Market Trends
Table 10. COVID-19 Impact Global Rheumatoid Arthritis (RA) Drugs Market Size
Table 11. Global Rheumatoid Arthritis (RA) Drugs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Rheumatoid Arthritis (RA) Drugs Market Growth Drivers
Table 14. Global Rheumatoid Arthritis (RA) Drugs Market Restraints
Table 15. Global Rheumatoid Arthritis (RA) Drugs Market Opportunities
Table 16. Global Rheumatoid Arthritis (RA) Drugs Market Challenges
Table 17. By Players, Rheumatoid Arthritis (RA) Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Rheumatoid Arthritis (RA) Drugs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Rheumatoid Arthritis (RA) Drugs Market
Table 21. Key Players Rheumatoid Arthritis (RA) Drugs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Rheumatoid Arthritis (RA) Drugs Market Size 2019-2021, (US$ Million)
Table 24. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Rheumatoid Arthritis (RA) Drugs Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Rheumatoid Arthritis (RA) Drugs Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product
Table 68. Johnson & Johnson Response to COVID-19 and Related Developments
Table 69. Amgen, Inc. Business Overview
Table 70. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product
Table 72. Amgen, Inc. Response to COVID-19 and Related Developments
Table 73. Pfizer Business Overview
Table 74. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Pfizer Rheumatoid Arthritis (RA) Drugs Product
Table 76. Pfizer Response to COVID-19 and Related Developments
Table 77. Merck Business Overview
Table 78. Merck Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Merck Rheumatoid Arthritis (RA) Drugs Product
Table 80. Merck Response to COVID-19 and Related Developments
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product
Table 84. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 85. UCB Business Overview
Table 86. UCB Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. UCB Rheumatoid Arthritis (RA) Drugs Product
Table 88. UCB Response to COVID-19 and Related Developments
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Product
Table 92. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 93. Sanofi Business Overview
Table 94. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sanofi Rheumatoid Arthritis (RA) Drugs Product
Table 96. Sanofi Response to COVID-19 and Related Developments
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product
Table 100. Abbott Laboratories Response to COVID-19 and Related Developments
Table 101. Teva Pharmaceutical Business Overview
Table 102. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product
Table 104. Teva Pharmaceutical Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Rheumatoid Arthritis (RA) Drugs Product Picture
Figure 2. Rheumatoid Arthritis (RA) Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Rheumatoid Arthritis (RA) Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Rheumatoid Arthritis (RA) Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size Market Share, 2019-2021
Figure 1. Rheumatoid Arthritis (RA) Drugs Product Picture
Figure 2. Rheumatoid Arthritis (RA) Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Rheumatoid Arthritis (RA) Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Rheumatoid Arthritis (RA) Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Rheumatoid Arthritis (RA) Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size Market Share, 2019-2021
